Results

Total Results: 3,789 records

Showing results for "choice".

3521. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
      December 01, 2011 - Layout 1 Background Coronary stents and adjunctive pharmacologic agents—including glycoprotein IIb/IIIa receptor inhibitors and thienopyridines—have improved the efficacy of percutaneous coronary intervention (PCI).1,2 However, dislodgement of atherothrombotic material from coronary lesions during PCI can result in …

3522. Renal Artery Stenosis Management Strategies: An Updated Comparative Effectiveness Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_executive.pdf
      August 01, 2016 - Renal Artery Stenosis Management Strategies: An Updated Comparative Effectiveness Review 1 Comparative Effectiveness Review Number 179 Renal Artery Stenosis Management Strategies: An Updated Comparative Effectiveness Review Executive Summary Background Atherosclerotic renal artery stenosis (ARAS) is increasin…

3523. Chartbook on Care Coordination: Slide Presentation | Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/nhqrdr/chartbooks/carecoordination/carecoordination-slides.html
      June 01, 2018 - Chartbook on Care Coordination: Slide Presentation National Healthcare Quality and Disparities Report Slide 1 National Healthcare Quality and Disparities Report Chartbook on Care Coordination June 2016 Slide 2 National Healthcare Quality and Disparities Report Annual report to Congress mandat…

3524. Making Healthcare Safer Practices: 9. Reducing Adverse Drug Events in Older Adults (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/reducing-adverse-drug-1.pdf
      March 01, 2020 - Making Healthcare Safer Practices: 9. Reducing Adverse Drug Events in Older Adults Reducing Adverse Drug Events in Older Adults 9-1 9. Reducing Adverse Drug Events in Older Adults Authors: Tara R. Earl, Ph.D., M.S.W., Nicole D. Katapodis, M.P.H., and Stephanie R. Schneiderman, M.P.P. Reviewers: Scott Winiecki, M.D…

3525. Final Progress Report: Racial and Ethnic Variations in Medical Interactions (pdf file)
      www.ahrq.gov/sites/default/files/2024-07/ashton-report.pdf
      January 01, 2024 - Final Progress Report: Racial and Ethnic Variations in Medical Interactions Title of Project Racial and Ethnic Variations in Medical Interactions Principal Investigator and Team Members Carol M. Ashton, MD, MPH (PI), Tracie C. Collins, MD, MPH, Coreen Domingo, MPH, Howard S. Gordon, MD…

3526. Pregnant & Postpartum Behavioral Health Integration | AHRQ
      integrationacademy.ahrq.gov/products/topic-briefs/pregnant-postpartum-women
      December 01, 2024 - An official website of the Department of Health & Human Services Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates The Academy Integrating Behavioral Health & Primary Care Expand Navi…

3527. Archived: Evidence Summary: Collaborative Modeling of U.S. Breast Cancer Screening Strategies: Breast Cancer: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-collaborative-modeling-of-us-breast-cancer-/breast-cancer-screening-january-2016
      January 11, 2016 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary: Collaborative Modeling of U.S. Breast Cancer Screening Strategies Breast Cancer: Screening January 11, 2016 Recommendations made by the USPSTF ar…

3528. Archived: Evidence Summary: Alcohol Misuse: Screening and Behavioral Counseling Interventions in Primary Care | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary9/alcohol-misuse-screening-and-behavioral-counseling-interventions-in-primary-care-2013
      September 25, 2012 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Alcohol Misuse: Screening and Behavioral Counseling Interventions in Primary Care September 25, 2012 Recommendations made by the USPSTF are independ…

3529. Archived: Final Evidence Summary: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary51/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
      April 08, 2014 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Evidence Summary Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication April 08, 2014 Recommendation…

3530. Expend (pdf file)
      meps.ahrq.gov/data_stats/nhc/expend.pdf
      September 30, 1997 - OMB # 0935-0099 EXPIRES: 09/30/97 SP ID #: PSF ID #: SP NAME: INTERVIEWER NAME: INTERVIEWER ID: DATE OF INTERVIEW: ________/______/_______ MONTH DAY YEAR TIME INTERVIEW BEGAN: am/pm Department of Health and Human Services Public Health Service Agency for Health Care Policy and Research and National Center for…

3531. Diagnostic Safety Across Transitions of Care Throughout the Healthcare System: Current State and a Call to Action (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/diagnostic-safety-transitions-care.pdf
      June 01, 2023 - Diagnostic Safety Across Transitions of Care Throughout the Healthcare System: Current State and a Call to Action PATIENT SAFETY e Issue Brief 11 Diagnostic Safety Across Transitions of Care Throughout the Healthcare System: Current State and a Call to Action This page intentionally left blank. e Issue …

3532. Challenges and Barriers to Clinical Decision Support (CDS) Design and Implementation Experienced in the Agency for Healthcare Research and Quality CDS Demonstrations (pdf file)
      digital.ahrq.gov/sites/default/files/docs/page/CDS_challenges_and_barriers.pdf
      July 30, 2007 - Challenges and Barriers to Clinical Decision Support (CDS) Design and Implementation Experienced in the Agency for Healthcare Research and Quality CDS Demonstrations Challenges and Barriers to Clinical Decision Support (CDS) Design and Implementation Experienced in the Agency for Healthcare Research and Quality …

3533. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/r3f2G_ReqS8tN48szHPCxt
      November 01, 2009 - Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms Jeanne S. Mandelblatt, MD, MPH; Kathleen A. Cronin, PhD; Stephanie Bailey, PhD; Do…

3534. Gout Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
      March 01, 2016 - 1 Comparative Effectiveness Review Number 176 Management of Gout Executive Summary Background and Objectives Gout is the most common form of inflammatory arthritis and is characterized by acute intermittent episodes of synovitis presenting with joint swelling and pain (referred to as acute gouty arthriti…

3535. Gout Executive-2016 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive-2016.pdf
      January 01, 2016 - 1 Comparative Effectiveness Review Number 158 Diagnosis of Gout Executive Summary Background Condition Gout is a form of inflammatory arthritis characterized by acute intermittent episodes of synovitis presenting with joint swelling and pain; the episodes are referred to as acute gouty arthritis flare…

3536. Wireless-Motility-Capsule Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_executive.pdf
      May 01, 2013 - 1 Comparative Effectiveness Review Number 110 Wireless Motililty Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation: A Comparative Effectiveness Review Executive Summary Gastroparesis Definition and Prevalence Gastroparesis is a condition in which patients experience …

3537. Mrsa-Screening-2010 Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_executive.pdf
      January 01, 2010 - 1 Comparative Effectiveness Review Number 102 Screening for Methicillin-Resistant Staphylococcus Aureus (MRSA) Executive Summary Background Methicillin-resistant Staphylococcus aureus (MRSA) emerged as a clinically relevant human pathogen more than five decades ago.1 The virulent bacterium was first detecte…

3538. Meditation Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
      January 01, 2014 - 1 Comparative Effectiveness Review Number 124 Meditation Programs for Psychological Stress and Well-Being Executive Summary Introduction Definition of Meditation The National Center for Complementary and Alternative Medicine defines meditation as a “mind-body” method. This category of complementary and …

3539. Osteoporosis-Bone-Fracture Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
      March 01, 2012 - 1 Comparative Effectiveness Review Number 53 Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: Update of a 2007 Report Executive Summary Background Osteoporosis is a systemic skeletal disease characterized by decreasing bone mass and microarchitectural deterioration of bo…

3540. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdf
      October 01, 2010 - Layout 1 Background Cystic fibrosis (CF) is the second most common life-shortening, childhood-onset genetic disease in the United States, affecting approximately 30,000 people in the Nation. The gene responsible for CF encodes the cystic fibrosis transmembrane regulator (CFTR) protein, which regulates sodium and chl…